Suven Pharmaceuticals Ltd.'s market cap is currently ₹347.93B. The company's EPS TTM is ₹1.6; its P/E ratio is 96.59; Suven Pharmaceuticals Ltd. is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is ₹2.53. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25
Dec 23
Dec 23
Dec 22
Dec 21
Currency in INR
Suven Pharmaceuticals Ltd. Earnings and Revenue History
